18 August 2017 - Deborah Wilkes
Archived
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has switched LEO Pharma's Dovonex (calcipotriol) from prescription to non-prescription status following a public consultation.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.